tiprankstipranks

David Colleran Insider Profile

4 Followers
David Colleran, EVP, GC, Corp Sec at Anika Therapeutics, holds 67.57K shares in Anika Therapeutics (Ticker: ANIK), holds 30.43K shares in Insulet (Ticker: PODD).
tipranks
David Colleran

David Colleran
Anika Therapeutics (ANIK)
EVP, GC, Corp Sec

Ranked #81,721 out of 108,921 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

-24.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
74.29%
25.71%
A breakdown of David Colleran's holdings

Insider Roles

Insulet
(PODD)
SVP, Secretary and GC
Anika Therapeutics
(ANIK)
EVP, GC, Corp Sec
Roles that David Colleran holds in companies

Most Profitable Insider Trade

Stock:
Anika Therapeutics
(ANIK)
Rating:Informative Buy
Date:May 12, 2022 - May 12, 2023
Return:+15.20%
The most profitable trade made by David Colleran

David Colleran's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Anika Therapeutics
Mar 17, 2026
EVP, GC, Corp Sec
Uninformative Buy
205.47K
$1.42M
Insulet
Apr 04, 2019
SVP, Secretary and GC
Uninformative Buy
229.10K
$4.10M
List of latest transactions for each holding click on a transaction to see David Colleran's performance on stock

David Colleran insider profile FAQ

What is the percentage of profitable transactions made by David Colleran?
The percentage of profitable transactions made by David Colleran is 67%.
    What is the average return per transaction made by David Colleran?
    The average return per transaction made by David Colleran is -24.00%.
      What stocks does David Colleran hold?
      David Colleran holds: ANIK, PODD stocks.
        What was David Colleran’s latest transaction?
        David Colleran latest transaction was an Uninformative Buy of $205.47K.
          What was David Colleran's most profitable transaction?
          David Colleran’s most profitable transaction was an Informative Buy of ANIK stock on May 12, 2022. The return on the trade was 15.20%.
            What is David Colleran's role in Anika Therapeutics?
            David Colleran's role in Anika Therapeutics is EVP, GC, Corp Sec.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.